-
1دورية أكاديمية
المؤلفون: Lipworth, Brian, Stewart, Kirsten, Chan, Rory
المصدر: Lipworth , B , Stewart , K & Chan , R 2022 , ' Pragmatic reappraisal of long-acting muscarinic antagonists at steps 4 and 5 for persistent adult asthma : Invited Perspective article for Annals of Allergy, Asthma and Immunology ' , Annals of Allergy, Asthma and Immunology , vol. 129 , no. 3 , pp. 274-275 . https://doi.org/10.1016/j.anai.2022.05.017Test
مصطلحات موضوعية: ong acting muscarinic antagonist, long acting beta-agonist, inhaled corticosteroid, triple inhaler, asthma exacerbations, asthma control Abbreviations AER: annualised exacerbation rate, COPD: chronic obstructive pulmonary disease, FeNO: fractional exhaled breath nitric oxide, FEV1: forced expiratory volume in 1s, GINA: global initiative for asthma, ICS: inhaled corticosteroid, LABA: long acting beta-agonist, LAMA: long acting muscarinic antagonist, Ppb: parts per billion, TTT: time to treat to prevent an exacerbation, /dk/atira/pure/subjectarea/asjc/2700/2740, name=Pulmonary and Respiratory Medicine, /dk/atira/pure/subjectarea/asjc/2700/2723, name=Immunology and Allergy, /dk/atira/pure/subjectarea/asjc/2400/2403, name=Immunology
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1016/j.anai.2022.05.017Test
https://discovery.dundee.ac.uk/en/publications/88b5c5f5-957d-4805-b9c1-3b5029856303Test
https://discovery.dundee.ac.uk/ws/files/79530899/PIIS1081120622004495.pdfTest
http://www.scopus.com/inward/record.url?scp=85132701890&partnerID=8YFLogxKTest -
2
المؤلفون: Seijiro Minamoto, Osamu Matsuno
المصدر: Respiratory Medicine Case Reports
Respiratory Medicine Case Reports, Vol 28, Iss, Pp-(2019)مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Severe asthma, Case Report, macromolecular substances, Eosinophil, BT, bronchial thermoplasty, 03 medical and health sciences, chemistry.chemical_compound, FAVORABLE RESPONSE, LABA, long-acting beta-agonist, 0302 clinical medicine, FeNO, fraction of exhaled nitric oxide, FVC - Forced vital capacity, Medicine, LTRA, leukotriene antagonist, Mepolizumab, lcsh:RC705-779, business.industry, Asthma symptoms, lcsh:Diseases of the respiratory system, Benralizumab, ICS, inhaled corticosteroids, ACT, Asthma control test, respiratory tract diseases, CT, computed tomography, medicine.anatomical_structure, LAMA, long-acting muscarinic antagonist, 030228 respiratory system, chemistry, 030220 oncology & carcinogenesis, Immunology, FVC, forced vital capacity, FEV1, expiratory volume in 1 second, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b4c679c8748f637452569268c870d10Test
http://europepmc.org/articles/PMC6630060Test